Buy Indian Hotels Ltd For Target Rs.170 - ICICI Direct
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Impacted by second wave…
About the stock: With room inventory of 19,425 rooms, Indian Hotels occupies a diversified position in the hotel industry through brands such as Taj, Vivanta, SeleQtions and Ginger brands.
* IHCL also has a selective presence in the luxury segment in the US, UK, Africa, Sri Lanka, the UAE and Maldives through owned/managed properties
* The company enjoys strong support from its key promoter Tata Sons and is also an important strategic business for the Tata Group.
Q1FY22 Results: Results remained weak, mainly impacted by second Covid wave.
* Revenues were down 44% QoQ to | 344.6 crore. Occupancy at standalone level was at 28.5%. However, average room rate saw a sharp jump of 45% YoY to | 7024/room leading to RevPAR growth of 101% YoY to | 1992/room
* Operational loss came in at ~| 149 crore vs. loss of | 266 crore last year
* The company reported net loss of | 242.3 crore
What should investors do?
The balance-sheet provides strong immunity to weather challenges while cost rationalisations would drive healthy margin expansion.
* We remain positive on the company and maintain our BUY rating
Target Price and Valuation: We value IHCL at | 170 i.e. 23x FY23E EV/EBITDA.
Key triggers for future price performance:
* The ongoing crisis to restrict overall room supply in the industry for next three to four years, auguring well for branded players like Indian Hotels
* The cost optimisation drive initiated in FY21 would provide fruitful results, going forward. Expect EBITDA margins of over 24% by FY23E
* The company has strong financial flexibility in terms of raising low cost debt if the need arises.
Alternate Stock Idea: Apart from Indian Hotels, in our hotel sector coverage we also like EIH.
* It is the premium segment key domestic hotel player. Like Taj, it also has strong hotel brands like Oberoi & Trident. It has a strong balance sheet
* BUY with a target price of | 150/share
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
Above views are of the author and not of the website kindly read disclaimer
